دانلود کتاب آنژیوپلاستی ریه با بالون در بیماران مبتلا به CTEPH

Chronic thromboembolic pulmonary hyperten-sion (CTEPH), classified as group 4 pulmonary hypertension (PH) in international guidelines, is a progressive disease of obstructive pulmonary arterial remodelling, usually identified as a result of single or multiple episodes of venous throm-boembolism (VTE). Indeed, three-quarters of CTEPH patients report a history of acute pulmo-nary embolism (PE), with a history of more than one episode of venous thromboembolism (VTE) in 34%. By comparison, a minority of patients do not have a documented history of VTE at pre-sentation. The median age at diagnosis is 63 years with an equal male:female ratio. Paediatric cases are rare. Epidemiological investigation of CTEPH gen-erally accounts for two routes of disease develop-ment: firstly, assessment of the cumulative incidence of the disease following an acute PE diagnosis, and secondly, estimation of population prevalence based on national PH registries that include CTEPH patients.